STAT3 Signaling Is Activated Preferentially in Tumor-Initiating Cells in Claudin-Low Models of Human Breast Cancer
Wei Wei(Institute of Process Engineering), Michael T. Lewis(Baylor College of Medicine), David J. Tweardy(The University of Texas MD Anderson Cancer Center), Susan G. Hilsenbeck(Baylor College of Medicine), John D. Landua(Baylor College of Medicine), Jeffrey M. Rosen(Baylor College of Medicine), Mei Zhang(Shanxi Medical University), Ivana Petrović(The University of Texas MD Anderson Cancer Center), Wen Bu(Baylor College of Medicine), Xiaomei Zhang(Tang Hospital), Kevin Roarty(Baylor College of Medicine)
Cited by 111
Related Papers
A single-cell survey of the small intestinal epithelium
|Nature|2017|1.9k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
|Nature|2017|853
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Preparation of Hierarchical Hollow CaCO<sub>3</sub> Particles and the Application as Anticancer Drug Carrier
|Journal of the American Chemical Society|2008|453